[1]
“THERAPEUTIC OPTIONS FOR PATIENTS WHO ARE NOT ELIGIBLE FOR INTENSIVE CHEMOTHERAPY”, Mediterr J Hematol Infect Dis, vol. 5, no. 1, p. e2013050, Jul. 2013, doi: 10.4084/mjhid.2013.050.